Stuart E. Lind
Impact in
- Cell Biology top 1%
- Cellular Mechanics and Interactions
- Oncology top 2%
- Cancer-related Molecular Pathways
- Metal complexes synthesis and properties
Papers in
- Hematology 14
- Blood Coagulation and Thrombosis Mechanisms 6
-
- Trace Elements in Health 7
- Co-authors
- Paul A. Janmey (9 shared papers)Thomas P. Stossel (8 shared papers)Bolin Liu (6 shared papers)Susan M. Edgerton (4 shared papers)Ann D. Thor (4 shared papers)Wei-Qun Ding (11 shared papers)Zeying Fan (3 shared papers)David B. Smith (4 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Cell Cycle (4 papers)Blood Coagulation & Fibrinolysis (3 papers)Molecular Cancer Therapeutics (3 papers)Cancer Letters (3 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Stuart E. Lind
80 papers receiving 5.7k citations
Stuart E. Lind's Hit Papers
Peers
Comparison fields: 5 of 174
- Cell Biology 904
- Oncology 1.2k
- Cancer Research 560
- Immunology and Allergy 212
- Internal Medicine 115
Countries citing papers authored by Stuart E. Lind
This map shows the geographic impact of Stuart E. Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Lind more than expected).
Fields of papers citing papers by Stuart E. Lind
This network shows the impact of papers produced by Stuart E. Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Lind. The network helps show where Stuart E. Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart E. Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonmuscle Actin-Binding Proteins Hit paper breakdown → | 1985 | 550 |
| 2 | 2009 | 454 | |
| 3 | 1990 | 388 | |
| 4 | 2009 | 353 | |
| 5 | 2005 | 226 | |
| 6 | 1977 | 223 | |
| 7 | Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. | 1988 | 219 |
| 8 | 1993 | 212 | |
| 9 | 1985 | 197 | |
| 10 | 2012 | 191 | |
| 11 | 1988 | 171 | |
| 12 | 1987 | 158 | |
| 13 | 1986 | 144 | |
| 14 | 2011 | 135 | |
| 15 | 1977 | 127 | |
| 16 | 2011 | 125 | |
| 17 | 2009 | 122 | |
| 18 | 1989 | 118 | |
| 19 | 2010 | 118 | |
| 20 | 2008 | 106 |
About Stuart E. Lind
Stuart E. Lind is a scholar working on Hematology, Nutrition and Dietetics, Internal Medicine, Cell Biology and Oncology, having authored 80 papers that have together received 6.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (7 papers), Blood properties and coagulation (7 papers), Cellular Mechanics and Interactions (7 papers), Trace Elements in Health (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (5 papers). The work is most often cited by research in Cell Biology (904 citations), Oncology (1.2k citations), Cancer Research (560 citations), Immunology and Allergy (212 citations) and Internal Medicine (115 citations). Stuart E. Lind has collaborated with scholars based in United States, China and France. Frequent co-authors include Paul A. Janmey, Thomas P. Stossel, Bolin Liu, Susan M. Edgerton, Ann D. Thor, Wei-Qun Ding, Zeying Fan, David B. Smith, Byron J. Good and Irina N. Alimova. Their work appears in journals such as Journal of Biological Chemistry, Cell Cycle, Blood Coagulation & Fibrinolysis, Molecular Cancer Therapeutics and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.